← All CLS Flashcard Decks

CLS Special Populations in Lipid Management Flashcards

6 cards from real CLS practice questions. Tap to flip, then mark Knew It or Still Learning — missed cards come back until you master them.

Read the first 6 CLS Special Populations in Lipid Management flashcards as text
  1. In patients with type 1 diabetes, what lipid abnormality is most commonly seen when diabetes is well-controlled?

    Answer: Near-normal lipid profiles, as insulin facilitates lipid metabolism

    Well-controlled type 1 diabetes is associated with near-normal or even above-normal HDL-C and relatively normal lipid profiles due to adequate insulin levels.

  2. A post-menopausal woman is considering hormone replacement therapy (HRT). Which lipid effect distinguishes oral from transdermal estrogen preparations?

    Answer: Oral estrogen increases triglycerides; transdermal estrogen has minimal triglyceride effect

    Oral estrogen undergoes first-pass hepatic metabolism, stimulating VLDL and triglyceride production, whereas transdermal estrogen bypasses the liver and has minimal triglyceride impact.

  3. In patients with metabolic syndrome, which lipid triad is characteristically found?

    Answer: Elevated triglycerides, low HDL-C, and increased small dense LDL particles

    Metabolic syndrome classically presents with the atherogenic dyslipidemia triad: hypertriglyceridemia, low HDL-C, and predominance of small dense LDL particles.

  4. Which statin dose adjustment is recommended in patients with severe hepatic impairment (Child-Pugh Class C)?

    Answer: Statins are contraindicated in active liver disease and severe hepatic impairment

    Statins are contraindicated in patients with active liver disease or unexplained persistent elevations of hepatic transaminases, including severe hepatic impairment.

  5. In patients undergoing solid organ transplantation on cyclosporine, which statin interaction is most clinically significant?

    Answer: Cyclosporine markedly increases statin levels by inhibiting CYP3A4 and OATP1B1, increasing myopathy risk

    Cyclosporine inhibits both CYP3A4 and OATP1B1 transporters, dramatically increasing systemic statin exposure and myopathy/rhabdomyolysis risk.

  6. In patients with hypothyroidism, what is the recommended approach to managing hyperlipidemia?

    Answer: Treat hypothyroidism first with thyroid hormone replacement before reassessing lipid levels

    Hypothyroidism is a reversible cause of dyslipidemia; correcting thyroid hormone deficiency often normalizes lipid levels, avoiding unnecessary statin therapy.

How this page was made: written with AI tools. Exam facts are checked against the official sources listed below. Not reviewed by a subject-matter expert. Editorial policy

Sources & references

Exam facts on this page (fees, format, dates, passing scores) are checked against these official sources; the date is our last check. Editorial policy

  1. lipidboard.org — Renewal, score validity, test delivery, exam format, time limit, fees, registration deadline, test dates · verified Oct 2026
CLS Special Populations in Lipid Management Flashcards — CLS Study Cards with Answers